ARIDIS PHARMACEUTICALS INC

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch ARDS and buy or sell other stocks, ETFs, and their options commission-free!

About ARDS

Aridis Pharmaceuticals, Inc. engages in the discovery and development of targeted immunotherapy using human monoclonal antibodies, or mAbs, to treat infections. The company was founded by Eric J. 

CEO
Vu L. Truong
CEOVu L. Truong
Employees
37
Employees37
Headquarters
Los Gatos, California
HeadquartersLos Gatos, California
Founded
2003
Founded2003
Employees
37
Employees37

ARDS Key Statistics

Market cap
8.91K
Market cap8.91K
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
37.43K
Average volume37.43K
High today
$0.0005
High today$0.0005
Low today
$0.0002
Low today$0.0002
Open price
$0.0002
Open price$0.0002
Volume
18.38K
Volume18.38K
52 Week high
$0.05
52 Week high$0.05
52 Week low
$0.00
52 Week low$0.00

Stock Snapshot

As of today, ARIDIS PHARMACEUTICALS INC(ARDS) shares are valued at $0.00. The company's market cap stands at 8.91K.

As of 2026-01-03, ARIDIS PHARMACEUTICALS INC(ARDS) stock has fluctuated between $0.00 and $0.00. The current price stands at $0.00, placing the stock 0.0% above today's low and -60.0% off the high.

The ARIDIS PHARMACEUTICALS INC(ARDS)'s current trading volume is 18.38K, compared to an average daily volume of 37.43K.

In the last year, ARIDIS PHARMACEUTICALS INC(ARDS) shares hit a 52-week high of $0.05 and a 52-week low of $0.00.

In the last year, ARIDIS PHARMACEUTICALS INC(ARDS) shares hit a 52-week high of $0.05 and a 52-week low of $0.00.

People also own

Based on the portfolios of people who own ARDS. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.